Medicine Information

Vioxx and Bextra Lawsuits Could Tie Up Courts for Years


In September, 2004, pharmaceutical giant Merck voluntarily withdrew its painkilling medication Vioxx from the market. Studies show that Vioxx increases the risk of heart attack and stroke among patients who have used the drug for longer than 18 months. Vioxx, a drug from a family of non-steroidal anti-inflammatory drugs known as COX-2 inhibitors, is one of only a few drugs specifically designed to minimize inflammation while avoiding the stomach disorders long associated with other anti-inflammatory medications. Since its introduction in 1999, Vioxx has been a huge success, and sales of the drug worldwide topped $2.5 billion in 2003. That is certainly a great deal of money, but it pales when compared to the amount that Merck stands to lose through product liability lawsuits, which will soon come to court. As of this writing, several thousand lawsuits have been filed nationally, but attorneys estimate that the total number of lawsuits filed could reach a staggering 100,000.

One hundred thousand lawsuits is certainly a formidable number, but that figure could represent only half of the number of lawsuits related to COX-2 inhibitors. Earlier this year, Pfizer voluntarily withdrew its similar medication Bextra from the market, as studies linked the use of Bextra to increased heart attack risk and to a rare skin disorder known as Stevens-Johnson Syndrome. Bextra, another drug in the family of COX-2 inhibitors, works very similarly to Vioxx, and many patients who formerly took Vioxx switched to Bextra after the former was removed from the market last fall. Given that sales of Bextra rose to near Vioxx levels before it was removed from the market, it seems likely that the number of lawsuits filed by patients who claim to have been harmed by their use of Bextra could eventually equal the number of Vioxx lawsuits.

Unless the courts consolidate them into just a few class-action suits, the 200,000 potential lawsuits stemming from problems with Bextra and Vioxx could cripple our courts for the next decade. Patients who believe that they may have been harmed through the use of either Bextra or Vioxx would be well advised to contact an attorney who specializes in pharmaceutical lawsuits as soon as possible. The wait for a resolution in court, particularly for Vioxx lawsuits, could be a very long one. Those who file quickly may get the fastest results.

©Copyright 2005 by Retro Marketing.

Charles Essmeier is the owner of Retro Marketing, a firm devoted to informational Websites, including Bextra-Info.net, a site devoted to the withdrawn drug Bextra and StructuredSettlementHelp.com, a site devoted to structured settlements.


MORE RESOURCES:
This RSS feed URL is deprecated, please update. New URLs can be found in the footers at https://news.google.com/news


Financial Times

Scientists develop electronic 'smart skin' for sports and medicine
Financial Times
Electronic “smart skin” devices are being developed to monitor the biochemistry of sweating sports players, the health of stroke patients and the heartbeat of sick babies, researchers told the American Association for the Advancement of Science meeting ...
Japanese researchers develop ultrathin, highly elastic skin displayEurekAlert

all 28 news articles »


KFDI

Flus, cold and cavities: How cold medicine can affect your kids teeth
KFDI
INDIANAPOLIS -- During this cold and flu season, dentists want you to take extra steps when giving cold and cough medicine to your children. Dentists at Indiana University Health report many of the liquid medications are chock full of sugars, which end ...

and more »


Healthcare IT News (blog)

Penn Medicine CISO: 3 Strategies every security team should have
Healthcare IT News (blog)
After all the cybersecurity threats and events in the last 12 months, infosec teams should focus on these priorities as the craft strategies into the future. By Dan Costantino. February 19, 2018. 09:08 AM. Share. cybersecurity threats. The information ...



Forbes

Is Gaming Technology 'Medicine's New Frontier?'
Forbes
The Internet is rife with articles about the potentially harmful effects of gaming. Psychologists and parents have been debating the pros and cons of the issue for decades now—namely whether video games promote violence, social isolation and obesity ...



Standard Speaker

New medicine effective in fighting high cholesterol
Standard Speaker
The new drug is expensive, about $14,000 a year before insurance for the twice-monthly self-injected medicine. Blum said insurance companies typically will cover the drug for patients who can't reach their cholesterol goals with the highest tolerated ...

and more »


Stuff.co.nz

Popular Arthrem medicine linked with potential harm to liver
Stuff.co.nz
Medsafe is advising members of the public taking the dietary supplement Arthrem of a potential risk of harm to the liver. A widely used supplement to relieve joint pain could harm the liver - and some users have needed hospital care, Medsafe warns ...
Warning of potential harm to liver associated with the natural medicine ArthremNew Zealand Doctor Online

all 6 news articles »


Campbell Medicine hosts first Research & Educational Symposium
Campbell University News
The Jerry M. Wallace School of Osteopathic Medicine was occupied with more than 100 resident physicians, medical students, faculty and staff during the first Research & Educational Symposium, a collaboration of five hospital sites with approximately 20 ...



How Modern Medicine Changed the Way People Die
Knowledge@Wharton
Death is as old as time itself. But it has also changed in modern times, with technology prolonging life, social media making death a shareable event, and most people checking out of this world in hospitals and nursing homes instead of at home. Haider ...



HuffPost South Africa

Local Black Women Breaking Down Barriers In Medicine
HuffPost South Africa
From the youngest black female hospital CEO to the country's first black female neurosurgeon — young women in medicine are trailblazing. These mbokodos, all in their thirties, are as inspirational as they are aspirational. And today we're celebrating ...



Analyst Initiates Coverage on Regenerative Medicine Biotech, $70 Target More than Triple Current Price
Streetwise Reports
Cantor analyst Elemer Piros Ph.D. wrote, "We believe that PolarityTE can revolutionize the field of regenerative medicine. The company achieved previously unseen results with its SkinTE autologous cell product in wound healing, demonstrating flawless ...


Google News

home | site map | Dr. Thad Thomas
© 2006